[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with HF-CKD-T2DM.\nHF-CKD-T2DM + NAFLD/NASH Categories:\n\nHF-CKD-T2DM with NAFLD/NASH\nHF-CKD-T2DM without NAFLD/NASH\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM",
    "section": "",
    "text": "Data Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with HF-CKD-T2DM.\nHF-CKD-T2DM + NAFLD/NASH Categories:\n\nHF-CKD-T2DM with NAFLD/NASH\nHF-CKD-T2DM without NAFLD/NASH\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout NAFLD/NASH\nN = 1,232,840\n1\nWith NAFLD/NASH\nN = 16,515\n1\np-value\n2\n\n\n\n\nAge, y\n68 (12)\n64 (11)\n&lt;0.001\n\n\nSex\n\n\n\n\n0.014\n\n\n    Female\n637,140 (52%)\n8,170 (49%)\n\n\n\n\n    Male\n595,700 (48%)\n8,345 (51%)\n\n\n\n\nRace\n\n\n\n\n&lt;0.001\n\n\n    White\n773,855 (63%)\n11,245 (68%)\n\n\n\n\n    Asian or Pacific Islander\n23,505 (1.9%)\n320 (1.9%)\n\n\n\n\n    Black\n292,480 (24%)\n2,825 (17%)\n\n\n\n\n    Hispanic\n111,010 (9.0%)\n1,680 (10%)\n\n\n\n\n    Native American\n7,570 (0.6%)\n100 (0.6%)\n\n\n\n\n    Other\n24,420 (2.0%)\n345 (2.1%)\n\n\n\n\nElixhauser comorbidity index\n8.22 (1.75)\n9.42 (1.77)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n0.035\n\n\n    $1 - $51,999\n436,800 (35%)\n5,515 (33%)\n\n\n\n\n    $52,000 - $65,999\n343,500 (28%)\n4,925 (30%)\n\n\n\n\n    $66,000 - $87,999\n277,615 (23%)\n3,815 (23%)\n\n\n\n\n    $88,000 or more\n174,925 (14%)\n2,260 (14%)\n\n\n\n\nExpected primary payer\n\n\n\n\n&lt;0.001\n\n\n    Private\n160,640 (13%)\n2,965 (18%)\n\n\n\n\n    Medicaid\n119,115 (9.7%)\n2,030 (12%)\n\n\n\n\n    Medicare\n930,880 (76%)\n11,200 (68%)\n\n\n\n\n    Other\n22,205 (1.8%)\n320 (1.9%)\n\n\n\n\nHospital region\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n366,130 (30%)\n5,425 (33%)\n\n\n\n\n    Northeast\n191,195 (16%)\n1,985 (12%)\n\n\n\n\n    South\n488,105 (40%)\n6,065 (37%)\n\n\n\n\n    West\n187,410 (15%)\n3,040 (18%)\n\n\n\n\nHospital bedsize\n\n\n\n\n0.009\n\n\n    Large\n613,710 (50%)\n8,710 (53%)\n\n\n\n\n    Medium\n354,220 (29%)\n4,520 (27%)\n\n\n\n\n    Small\n264,910 (21%)\n3,285 (20%)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n0.5\n\n\n    Rural\n104,480 (8.5%)\n1,295 (7.8%)\n\n\n\n\n    Urban, non-teaching\n236,055 (19%)\n3,250 (20%)\n\n\n\n\n    Urban, teaching\n892,305 (72%)\n11,970 (72%)\n\n\n\n\nHypertension\n1,201,435 (97%)\n16,010 (97%)\n0.064\n\n\nHyperlipidemia\n792,610 (64%)\n11,355 (69%)\n&lt;0.001\n\n\nCoronary artery disease\n607,995 (49%)\n7,800 (47%)\n0.019\n\n\nPeripheral vascular disease\n169,000 (14%)\n2,245 (14%)\n0.8\n\n\nChronic obstructive pulmonary disease\n535,775 (43%)\n7,585 (46%)\n0.005\n\n\nDementia\n79,535 (6.5%)\n680 (4.1%)\n&lt;0.001\n\n\nObstructive sleep apnea\n383,310 (31%)\n6,770 (41%)\n&lt;0.001\n\n\nAlcohol use disorder\n372,000 (30%)\n6,040 (37%)\n&lt;0.001\n\n\nValvular heart disease\n211,195 (17%)\n2,800 (17%)\n0.8\n\n\nAtrial Fibrillation\n410,000 (33%)\n5,245 (32%)\n0.083\n\n\nCancer\n47,235 (3.8%)\n520 (3.1%)\n0.046\n\n\nObesity\n1,026,165 (83%)\n14,895 (90%)\n&lt;0.001\n\n\n\n1\nMean (SD); n (%)\n\n\n2\nDesign-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nWithout NAFLD/NASH\nN = 1,232,840\n1\nWith NAFLD/NASH\nN = 16,515\n1\np-value\n2\n\n\n\n\nDied during hospitalization\n50,915 (4.1%)\n530 (3.2%)\n0.009\n\n\nLength of stay (days)\n7.1 (7.5)\n7.0 (6.8)\n0.6\n\n\nInflation-adjusted total charge ($)\n83,797 (123,979)\n82,383 (98,827)\n&lt;0.001\n\n\n\n1\nn (%); Mean (SD)\n\n\n2\nPearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR\n1\n95% CI\n1\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Without NAFLD/NASH\n—\n—\n\n\n\n\n    With NAFLD/NASH\n0.60\n0.49, 0.73\n&lt;0.001\n\n\nAge, y\n1.02\n1.01, 1.02\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n1.13\n1.08, 1.18\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n1.03\n0.90, 1.18\n0.6\n\n\n    Black\n0.92\n0.86, 0.97\n0.003\n\n\n    Hispanic\n1.06\n0.98, 1.14\n0.12\n\n\n    Native American\n1.28\n1.01, 1.62\n0.038\n\n\n    Other\n1.07\n0.93, 1.24\n0.3\n\n\nElixhauser comorbidity index\n1.48\n1.46, 1.51\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n0.92\n0.87, 0.97\n0.003\n\n\n    $66,000 - $87,999\n0.91\n0.86, 0.97\n0.002\n\n\n    $88,000 or more\n0.93\n0.87, 0.99\n0.032\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.81\n0.73, 0.89\n&lt;0.001\n\n\n    Medicare\n0.90\n0.84, 0.96\n0.003\n\n\n    Other\n1.34\n1.15, 1.55\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n1.12\n1.04, 1.21\n0.003\n\n\n    South\n0.91\n0.86, 0.97\n0.003\n\n\n    West\n0.94\n0.87, 1.01\n0.10\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n0.94\n0.89, 0.99\n0.019\n\n\n    Small\n0.86\n0.81, 0.92\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n1.22\n1.10, 1.35\n&lt;0.001\n\n\n    Urban, teaching\n1.29\n1.17, 1.41\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.54\n0.48, 0.60\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.62\n0.59, 0.65\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.85\n0.81, 0.89\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.68\n0.64, 0.72\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.63\n0.60, 0.66\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.97\n0.90, 1.04\n0.4\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.73\n0.69, 0.77\n&lt;0.001\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.76\n0.72, 0.80\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.60\n0.57, 0.64\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.91\n0.87, 0.96\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.81\n0.74, 0.89\n&lt;0.001\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.44\n0.42, 0.46\n&lt;0.001\n\n\n\n1\nOR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Clinical Outcomes of NAFLD/NASH in HF-CKD-T2DM",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\n1\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Without NAFLD/NASH\n—\n—\n\n\n\n\n    With NAFLD/NASH\n-1.1\n-1.3, -0.86\n&lt;0.001\n\n\nAge, y\n-0.03\n-0.03, -0.02\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n0.13\n0.07, 0.20\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n0.19\n-0.08, 0.46\n0.2\n\n\n    Black\n0.17\n0.08, 0.26\n&lt;0.001\n\n\n    Hispanic\n-0.05\n-0.18, 0.08\n0.4\n\n\n    Native American\n0.03\n-0.34, 0.39\n0.9\n\n\n    Other\n0.34\n0.11, 0.58\n0.004\n\n\nElixhauser comorbidity index\n1.0\n0.98, 1.0\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-0.10\n-0.18, -0.01\n0.021\n\n\n    $66,000 - $87,999\n-0.05\n-0.14, 0.04\n0.3\n\n\n    $88,000 or more\n0.02\n-0.09, 0.14\n0.7\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n0.11\n-0.05, 0.27\n0.2\n\n\n    Medicare\n-0.35\n-0.45, -0.25\n&lt;0.001\n\n\n    Other\n-0.09\n-0.33, 0.15\n0.5\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n0.83\n0.67, 0.99\n&lt;0.001\n\n\n    South\n0.26\n0.14, 0.37\n&lt;0.001\n\n\n    West\n-0.62\n-0.77, -0.46\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-0.80\n-0.90, -0.69\n&lt;0.001\n\n\n    Small\n-1.3\n-1.4, -1.2\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n0.99\n0.85, 1.1\n&lt;0.001\n\n\n    Urban, teaching\n1.8\n1.7, 1.9\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.55\n-0.75, -0.35\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.0\n-1.1, -0.95\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.49\n-0.55, -0.43\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.94\n-1.0, -0.84\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.2\n-1.3, -1.1\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n0.03\n-0.10, 0.15\n0.7\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.44\n-0.50, -0.37\n&lt;0.001\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-1.3\n-1.4, -1.2\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.98\n-1.1, -0.90\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.30\n-0.36, -0.23\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-0.22\n-0.38, -0.05\n0.012\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2.3\n-2.4, -2.2\n&lt;0.001\n\n\n\n1\nCI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta\n95% CI\n1\np-value\n\n\n\n\nCategories\n\n\n\n\n\n\n\n\n    Without NAFLD/NASH\n—\n—\n\n\n\n\n    With NAFLD/NASH\n-16,860\n-20,223, -13,496\n&lt;0.001\n\n\nAge, y\n-632\n-689, -574\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n\n\n    Female\n—\n—\n\n\n\n\n    Male\n6,839\n5,805, 7,873\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n\n\n    White\n—\n—\n\n\n\n\n    Asian or Pacific Islander\n9,206\n1,785, 16,627\n0.015\n\n\n    Black\n-1,321\n-3,071, 429\n0.14\n\n\n    Hispanic\n15,750\n12,711, 18,789\n&lt;0.001\n\n\n    Native American\n-8,387\n-14,462, -2,312\n0.007\n\n\n    Other\n26,111\n19,707, 32,515\n&lt;0.001\n\n\nElixhauser comorbidity index\n12,940\n12,270, 13,610\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n\n\n    $1 - $51,999\n—\n—\n\n\n\n\n    $52,000 - $65,999\n-503\n-2,088, 1,082\n0.5\n\n\n    $66,000 - $87,999\n-731\n-2,666, 1,205\n0.5\n\n\n    $88,000 or more\n3,495\n660, 6,331\n0.016\n\n\nExpected primary payer\n\n\n\n\n\n\n\n\n    Private\n—\n—\n\n\n\n\n    Medicaid\n-8,345\n-11,113, -5,577\n&lt;0.001\n\n\n    Medicare\n-6,217\n-8,293, -4,141\n&lt;0.001\n\n\n    Other\n-674\n-5,671, 4,322\n0.8\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Midwest\n—\n—\n\n\n\n\n    Northeast\n20,514\n16,461, 24,567\n&lt;0.001\n\n\n    South\n15,052\n12,535, 17,569\n&lt;0.001\n\n\n    West\n39,263\n34,052, 44,474\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Large\n—\n—\n\n\n\n\n    Medium\n-13,244\n-16,240, -10,248\n&lt;0.001\n\n\n    Small\n-23,156\n-26,102, -20,209\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n\n\n    Rural\n—\n—\n\n\n\n\n    Urban, non-teaching\n28,366\n25,711, 31,022\n&lt;0.001\n\n\n    Urban, teaching\n40,399\n38,031, 42,767\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-6,861\n-10,245, -3,476\n&lt;0.001\n\n\nHyperlipidemia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,564\n-11,824, -9,305\n&lt;0.001\n\n\nCoronary artery disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n2,297\n1,248, 3,347\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,433\n-12,232, -8,633\n&lt;0.001\n\n\nChronic obstructive pulmonary disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-16,155\n-17,523, -14,788\n&lt;0.001\n\n\nDementia\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-10,033\n-11,748, -8,319\n&lt;0.001\n\n\nObstructive sleep apnea\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-8,770\n-9,818, -7,723\n&lt;0.001\n\n\nAlcohol use disorder\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-12,249\n-15,332, -9,167\n&lt;0.001\n\n\nValvular heart disease\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-3,103\n-4,681, -1,526\n&lt;0.001\n\n\nAtrial Fibrillation\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,662\n-3,879, -1,445\n&lt;0.001\n\n\nCancer\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-2,656\n-5,260, -52\n0.046\n\n\nObesity\n\n\n\n\n\n\n\n\n    No\n—\n—\n\n\n\n\n    Yes\n-25,350\n-27,550, -23,151\n&lt;0.001\n\n\n\n1\nCI = Confidence Interval"
  }
]